SK Bioscience Co Ltd (302440) — Cash Flow Quality Index
SK Bioscience Co Ltd (302440) has a Cash Flow Quality Index of 0.84x as of September 2025. Operating cash flow of ₩20.65 Billion is below net income of ₩24.48 Billion, suggesting accrual-heavy earnings not yet converted to cash. Also explore how large is SK Bioscience Co Ltd's balance sheet for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
SK Bioscience Co Ltd Cash Flow Quality Index (2018–2023)
Historical Cash Flow Quality Index for SK Bioscience Co Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check SK Bioscience Co Ltd (302440) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for SK Bioscience Co Ltd (2018–2023)
Year-by-year earnings quality comparison for SK Bioscience Co Ltd. For live market cap and the full company financial profile, see market value of SK Bioscience Co Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 1.31x | ₩29.35 Billion | ₩22.32 Billion | ▲ +228.9% |
| 2022 | -1.02x | ₩-124.96 Billion | ₩122.45 Billion | ▼ -167.5% |
| 2021 | 1.51x | ₩536.59 Billion | ₩355.14 Billion | ▼ -58.7% |
| 2020 | 3.66x | ₩120.22 Billion | ₩32.89 Billion | ▲ +200.0% |
| 2019 | 1.22x | ₩21.82 Billion | ₩17.91 Billion | ▼ -96.6% |
| 2018 | 35.41x | ₩14.90 Billion | ₩420.84 Million | — |